期刊文献+

特发性中枢性性早熟女童GnRHa治疗前后心理行为的变化 被引量:13

Psychological behavior of girls with idiopathic central precocious puberty before and after treatment with gonadotropin-releasing hormone analogue
下载PDF
导出
摘要 目的:了解特发性中枢性性早熟(ICPP)女童心理行为改变与血清脱氢表雄酮(DHEA)、硫酸脱氢表雄酮(DHEAS)的关系,探讨长效促性腺激素类似物(GnRHa)在逆转或阻断ICPP女童不良心理行为中的作用。方法:由专人采用瑞文标准推理测验、艾氏儿童行为量表、自尊量表(SES)、躯体自信量表(BES)等对确诊ICPP女童和对照组女童进行心理行为的评估,用ELISA法检测DHEA、DHEAS水平,并对GnRHa治疗的ICPP女童进行DHEA、DHEAS及心理行为的随访。结果:1ICPP女童SES、BES的评分明显低于对照组(P<0.05);而艾氏儿童行为量表的抑郁、退缩、攻击性、体诉这4个因子的评分,ICPP组女童明显高于对照组(P<0.05);2ICPP组女童经GnRHa治疗12个月后,SES、BES得分有改善,治疗前、后比较差异有显著意义(P<0.05)。ICPP组女童GnRHa治疗前血清DHEA为Log(0.77±0.36)μg/L,明显高于对照组Log(0.28±0.22)μg/L(P<0.01);GnRHa治疗后3个月,DHEA和DHEAS浓度明显下降;而治疗12个月时,DHEA和DHEAS与治疗前比较差异无显著意义(P>0.05)。3ICPP女童SES的分值和BES中的体重关注、身体耐力2个分值与DHEA呈负相关(r分别为-0.492、-0.356、-0.202和-0.216,P均<0.05);而艾氏儿童行为量表的9个因子与DHEA无相关关系。结论:ICPP女童存在自尊程度低,自信心不足,且这种自尊程度和自信心不足随体内DHEA水平的增高而更加明显;性早熟女童更容易表现为抑郁、退缩、攻击性和好抱怨,但与体内DHEA水平变化无关;GnRHa治疗能不同程度地逆转ICPP女童的自尊程度低和自信心不足。 Objective: To observe the psychological behavior of girls with idiopathic central precocious puberty (ICPP) before and after treatment by gonadotropin-releasing hormone analogue (GnRHa). Methods: Raven's Standard Progressive Matrices (SPM), Achenbach's Child Behavior Checklist (CBCL),Self-Esteem Scale (SES),and Body-Esteem Scale (BES) were used to assess the psychological behavior in the ICPP girls before and after GnRHa treatment,as well as in control girls. The serum levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) were measured by ELISA before and after GnRHa treatment. Results: (1) The SES and BES scores in ICPP were significantly lower than those of controls (P〈0.05). The CBCL scores in depressed,withdrawn,aggressive and somatic complaint assessment were significantly higher in ICPP group than those of control group. (2) The SES score,the body strength scores for BES 12 months after treatment were significantly higher than those pretreatment (P〈0. 05). Serum DHEA levels in ICPP group and control group were Log (0. 77±0. 36)μg/L and Log (0.28 ±0.22)μg/L respectively, with a significant difference (P〈 0.01). Serum DHEA and DHEAS of ICPP 3 months after treatment were decreased from Log (0. 83±0.35)μg/L and Log(2.27±0. 30)μg/L to Log(0.68±0.44)μg/L and Log(2.11±0.43) μg/L (both P〈0. 05). The serum DHEA and DHEAS levels 12 months after treatment were Log (0. 78± 0. 30)μg/L and Log (2.40±0.34)μg/L, there was no significant difference before and after treatment(P〉0.05). (3) The SES score,the weight concern and body strength scores for BES were negatively correlated with serum DHEA and DHEAS levels in precocious puberty girls (r=-0. 492,-0. 356,-0.202 and -0. 216,all P〈0.05). The nine CBCL factors were not correlated with serum DHEA levels. Conclusions: Precocious puberty girls are prone to lower self-esteem and less confidence,which are correlated with the increase of serum DHEA levels. There is more frequency to be depressed, withdrawn, aggressive and complaining in these girls, however,which are not correlated with serum DHEA levels. GnRHa may reverse the problem of psychological behavior in ICPP girls.
出处 《浙江大学学报(医学版)》 CAS CSCD 2008年第3期289-294,共6页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省科技厅科技基金(编号:2004C33035) 浙江省教育厅科技基金(编号:20040213)
关键词 青春期 早熟/药物疗法 青春期 早熟 促性腺素释放激素/类似物和衍生物 促性腺素释放激素/治疗应用 儿童心理学 Puberty, precocious/drug ther Puberty, precocious Gonadorelin/analogs Gonadorelin/ther use Child psychology
  • 相关文献

参考文献17

  • 1DUMin-lian(杜敏联).Endocrinology of adolescence (青春期内分泌学)[M].Beijing : RenMin Sanitary Press, 2006 : 158-197.
  • 2DUMin-lian(杜敏联).Recommendations for the diagnosis and treatment of central precocious puberty .中华儿科杂志,2007,45(5):426-427.
  • 3SALERNO M, DI MAIO S, GASPARINI N, et al. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment [J]. Horm Res,1998,50(4):205-211.
  • 4LERNER J A,INIUIS T S,TRUPIN E W,et al. Preschool behavior can predict future psychiatric disorders [J].J Am Aradd Child Psychiatry, 1985,25:42-48.
  • 5MUL D, VERSLUIS-DEN BIEMAN H J, SLIJPER F M,et al. Psychological assessments before and after treat of early puberty in adopted children [J]. Acta Paediatr, 2001,90 (9) : 965- 971.
  • 6ANTONIAZZI F, ZAMBONI G. Central precocious puberty: current treatment options [J]. Paediatr Drugs,2004,6(4) :211-231.
  • 7BARBACCIA M L,SERRA M,PURDY R H,et al. Stress and neuroactive steroids [J]. Int Rev Neurobiol, 2001,46:243-272.
  • 8FADALTI M,PETRAGLIA F,LUISI S,et al. Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development [J]. Pediatr Res, 1999,46:323-327.
  • 9NICOLAS L B,PINOTEAU W,PAPOT S,et al. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice [J]. Brain Res,2001,922(2): 216-222.
  • 10MURPHY B E. Steroids and depression[J]. J Seroid Biochem Mol Bio, 1991,38 : 537-559.

二级参考文献22

  • 1[1]Baulieu EE. Neurosteroids: a novel function of the brain [J]. Psychoneuroendocrinology, 1998, 23(8):963- 987.
  • 2[2]Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance [J]. Prog Neurobiol , 1992, 38 (4):379 - 395.
  • 3[3]Schumacher M, Robert F, Baulieu EE. Neurosteroids:trophic effects in the nervous system[J]. J Soc Biol, 1999,193(3) :285 - 292.
  • 4[4]Kroboth PD, Salek FS, Pittenger AL, et al. DHEA and DHEA-S: a review[J]. J Clin Pharmacol, 1999, 39(4):327 - 348.
  • 5[5]Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives[J]. Trends Neurosci, 1999, 22(9) :410- 416.
  • 6[6]Pallares M, Darnaudery M, Day J, et al. The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory[J]. Neuroscience, 1998, 87(3) :551 - 558.
  • 7[7]Vallee M, Mayo W, Darnaudery M, et al. Neurosteroids:deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus[ J ]. Proc Natl Acad Sci USA, 1997, 94(26): 14865 - 14870.
  • 8[8]Damaudery M, Pallares M, Bouyer JJ, et al. Infusion of neurosteroids into rat nucleus basalis affects paradoxical sleep in accordance with their memory modulating properties [J]. Neuroscience, 1999, 92(2):583-588.
  • 9[9]Kimonides VG, Spillantini MG, Sofroniew MV, et al. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures [J]. Neuroscience, 1999, 89(2) :429 - 436.
  • 10[10]Maurice T, Su TP, Privat A, et al. Sigma 1 (σ1) receptor agonists and neurosteroids attenuate β25-35-amyloid peptide-induced amnesia in mice through a common mechanism [J]. Neuroscience, 1998, 83(2) :413 - 428.

共引文献2

同被引文献147

引证文献13

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部